Novel Potential Blood Biomarkers for Detection of Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors.
作者信息
Leerink Jan M, Feijen Elizabeth A M
机构信息
Amsterdam UMC, University of Amsterdam, Heart Center, Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
出版信息
JACC CardioOncol. 2025 Jan 21;7(1):68-69. doi: 10.1016/j.jaccao.2024.11.005. eCollection 2025 Jan.
Abstract
摘要
相似文献
1
Novel Potential Blood Biomarkers for Detection of Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors.
JACC CardioOncol. 2025 Jan 21;7(1):68-69. doi: 10.1016/j.jaccao.2024.11.005. eCollection 2025 Jan.
2
Candidate Plasma Biomarkers to Detect Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study.
J Am Heart Assoc. 2022 Jul 19;11(14):e025935. doi: 10.1161/JAHA.121.025935. Epub 2022 Jul 13.
3
Serum Proteins Predict Treatment-Related Cardiomyopathy Among Survivors of Childhood Cancer.
JACC CardioOncol. 2024 Dec 3;7(1):56-67. doi: 10.1016/j.jaccao.2024.10.004. eCollection 2025 Jan.
4
Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer-A Children's Oncology Group ALTE03N1 report.
Cancer. 2020 Sep 1;126(17):4051-4058. doi: 10.1002/cncr.32948. Epub 2020 May 15.
5
DNA Damage Response and Repair Genes and Anthracycline-Induced Cardiomyopathy in Childhood Cancer Survivors: A Report From the Children's Oncology Group and the Childhood Cancer Survivor Study.
Circ Genom Precis Med. 2025 Apr;18(2):e004813. doi: 10.1161/CIRCGEN.124.004813. Epub 2025 Mar 28.
6
Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report.
J Am Heart Assoc. 2023 Oct 3;12(19):e029954. doi: 10.1161/JAHA.123.029954. Epub 2023 Sep 26.
7
Genome-Wide Association Study Identifies as a Novel Susceptibility Gene for Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors.
J Clin Oncol. 2023 Mar 20;41(9):1758-1769. doi: 10.1200/JCO.22.01527. Epub 2022 Dec 12.
8
Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy.
Sci Rep. 2023 Aug 4;13(1):12683. doi: 10.1038/s41598-023-39357-2.
9
Cardiac biomarkers and association with subsequent cardiomyopathy and mortality among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort.
Cancer. 2021 Feb 1;127(3):458-466. doi: 10.1002/cncr.33292. Epub 2020 Oct 27.
10
Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A COG-ALTE03N1 Report.
JACC CardioOncol. 2023 Feb 7;5(3):392-401. doi: 10.1016/j.jaccao.2022.09.009. eCollection 2023 Jun.
本文引用的文献
1
Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Lancet Oncol. 2023 Mar;24(3):e108-e120. doi: 10.1016/S1470-2045(23)00012-8. Epub 2023 Feb 14.
2
Candidate Plasma Biomarkers to Detect Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study.
J Am Heart Assoc. 2022 Jul 19;11(14):e025935. doi: 10.1161/JAHA.121.025935. Epub 2022 Jul 13.
3
Cardiac biomarkers and association with subsequent cardiomyopathy and mortality among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort.
Cancer. 2021 Feb 1;127(3):458-466. doi: 10.1002/cncr.33292. Epub 2020 Oct 27.
4
Long-term survivors of early breast cancer treated with chemotherapy are characterized by a pro-inflammatory biomarker profile compared to matched controls.
Eur J Heart Fail. 2020 Jul;22(7):1239-1246. doi: 10.1002/ejhf.1758. Epub 2020 Feb 20.
5
Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort.
BMJ. 2020 Jan 15;368:l6794. doi: 10.1136/bmj.l6794.
6
Risk and Temporal Changes of Heart Failure Among 5-Year Childhood Cancer Survivors: a DCOG-LATER Study.
J Am Heart Assoc. 2019 Jan 8;8(1):e009122. doi: 10.1161/JAHA.118.009122.
7
Bioinformatics identification of potential candidate blood indicators for doxorubicin-induced heart failure.
Exp Ther Med. 2018 Sep;16(3):2534-2544. doi: 10.3892/etm.2018.6482. Epub 2018 Jul 19.
8
Biomarkers to diagnose ventricular dysfunction in childhood cancer survivors: a systematic review.
Heart. 2019 Feb;105(3):210-216. doi: 10.1136/heartjnl-2018-313634. Epub 2018 Aug 29.
9
New signal transduction paradigms in anthracycline-induced cardiotoxicity.
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1916-25. doi: 10.1016/j.bbamcr.2016.01.021. Epub 2016 Jan 29.
10
Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors.
Clin Cancer Res. 2014 Dec 15;20(24):6314-23. doi: 10.1158/1078-0432.CCR-13-3490. Epub 2014 Jun 19.
Zotero 插件